Recombinant Anti-FGFR1 x Anti-KLB Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can bind two factors simultaneously and act as mimetic hormone (FGF21) . It is designed for the research of Type 2 diabetes therapy.
There are currently no customer reviews or questions for Recombinant Anti-FGFR1 x Anti-KLB Bispecific Antibody (CrossMab) (CROSSAB-161). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS